 | • レポートコード：MRC2012A2209 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、混合ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。混合ワクチンの種類別市場規模（髄膜炎菌ワクチン、日本脳炎ワクチン、黄熱病ワクチン、肝炎ワクチン、コレラワクチン、その他）、用途別市場規模（成人、子供）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：GSK、Biokangtai、Pfizer、Sanofi Pasteur、Serum Institute of India、Merck、Sanofi Pasteur MSD、CNBG、 ・地域別グローバル市場分析 2015年-2020年 ・混合ワクチンの北米市場（アメリカ、カナダ、メキシコ） ・混合ワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・混合ワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・混合ワクチンの南米市場（ブラジル、アルゼンチン） ・混合ワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：髄膜炎菌ワクチン、日本脳炎ワクチン、黄熱病ワクチン、肝炎ワクチン、コレラワクチン、その他 ・用途別分析：成人、子供 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Combination Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Combination Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Combination Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Combination Vaccine market has been segmented into
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other
By Application, Combination Vaccine has been segmented into:
Adults
Children
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Combination Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Combination Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Combination Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Combination Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Combination Vaccine Market Share Analysis
Combination Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Combination Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Combination Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Combination Vaccine are:
GSK
Biokangtai
Pfizer
Sanofi Pasteur
Serum Institute of India
Merck
Sanofi Pasteur MSD
CNBG
Among other players domestic and global, Combination Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Combination Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Combination Vaccine, with price, sales, revenue and global market share of Combination Vaccine in 2018 and 2019.
Chapter 3, the Combination Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Combination Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Combination Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Combination Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Combination Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Combination Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Meningococcal Vaccine
1.2.3 Japanese Encephalitis Vaccine
1.2.4 Yellow Fever Vaccine
1.2.5 Hepatitis Vaccine
1.2.6 Cholera Vaccine
1.2.7 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Combination Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Adults
1.3.3 Children
1.4 Overview of Global Combination Vaccine Market
1.4.1 Global Combination Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GSK SWOT Analysis
2.1.4 GSK Product and Services
2.1.5 GSK Combination Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Biokangtai
2.2.1 Biokangtai Details
2.2.2 Biokangtai Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Biokangtai SWOT Analysis
2.2.4 Biokangtai Product and Services
2.2.5 Biokangtai Combination Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Combination Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sanofi Pasteur
2.4.1 Sanofi Pasteur Details
2.4.2 Sanofi Pasteur Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sanofi Pasteur SWOT Analysis
2.4.4 Sanofi Pasteur Product and Services
2.4.5 Sanofi Pasteur Combination Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Serum Institute of India
2.5.1 Serum Institute of India Details
2.5.2 Serum Institute of India Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Serum Institute of India SWOT Analysis
2.5.4 Serum Institute of India Product and Services
2.5.5 Serum Institute of India Combination Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck SWOT Analysis
2.6.4 Merck Product and Services
2.6.5 Merck Combination Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sanofi Pasteur MSD
2.7.1 Sanofi Pasteur MSD Details
2.7.2 Sanofi Pasteur MSD Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sanofi Pasteur MSD SWOT Analysis
2.7.4 Sanofi Pasteur MSD Product and Services
2.7.5 Sanofi Pasteur MSD Combination Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 CNBG
2.8.1 CNBG Details
2.8.2 CNBG Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 CNBG SWOT Analysis
2.8.4 CNBG Product and Services
2.8.5 CNBG Combination Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Combination Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Combination Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Combination Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Combination Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Combination Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Combination Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Combination Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Combination Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Combination Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Combination Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Combination Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Combination Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Combination Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Combination Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Combination Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Combination Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Combination Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Combination Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Combination Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Combination Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Combination Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Combination Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Combination Vaccine Sales and Growth Rate (2015-2020)
6.4 France Combination Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Combination Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Combination Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Combination Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Combination Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Combination Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Combination Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Combination Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Combination Vaccine Sales and Growth Rate (2015-2020)
7.5 India Combination Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Combination Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Combination Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Combination Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Combination Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Combination Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Combination Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Combination Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Combination Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Combination Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Combination Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Combination Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Combination Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Combination Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Combination Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Combination Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Combination Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Combination Vaccine Price by Type (2015-2020)
11 Global Combination Vaccine Market Segment by Application
11.1 Global Combination Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Combination Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Combination Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Combination Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Combination Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Combination Vaccine Market Forecast (2021-2025)
12.2.2 Europe Combination Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Combination Vaccine Market Forecast (2021-2025)
12.2.4 South America Combination Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Combination Vaccine Market Forecast (2021-2025)
12.3 Combination Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Combination Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Combination Vaccine Market Share Forecast by Type (2021-2025)
12.4 Combination Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Combination Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Combination Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Combination Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Combination Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Combination Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Combination Vaccine Major Business
Table 9. GSK Combination Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. GSK SWOT Analysis
Table 11. GSK Combination Vaccine Product and Services
Table 12. GSK Combination Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Biokangtai Basic Information, Manufacturing Base and Competitors
Table 14. Biokangtai Combination Vaccine Major Business
Table 15. Biokangtai Combination Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. Biokangtai SWOT Analysis
Table 17. Biokangtai Combination Vaccine Product and Services
Table 18. Biokangtai Combination Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Combination Vaccine Major Business
Table 21. Pfizer Combination Vaccine Total Revenue (USD Million) (2017-2018)
Table 22. Pfizer SWOT Analysis
Table 23. Pfizer Combination Vaccine Product and Services
Table 24. Pfizer Combination Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 26. Sanofi Pasteur Combination Vaccine Major Business
Table 27. Sanofi Pasteur Combination Vaccine Total Revenue (USD Million) (2017-2018)
Table 28. Sanofi Pasteur SWOT Analysis
Table 29. Sanofi Pasteur Combination Vaccine Product and Services
Table 30. Sanofi Pasteur Combination Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 32. Serum Institute of India Combination Vaccine Major Business
Table 33. Serum Institute of India Combination Vaccine Total Revenue (USD Million) (2017-2018)
Table 34. Serum Institute of India SWOT Analysis
Table 35. Serum Institute of India Combination Vaccine Product and Services
Table 36. Serum Institute of India Combination Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Merck Basic Information, Manufacturing Base and Competitors
Table 38. Merck Combination Vaccine Major Business
Table 39. Merck Combination Vaccine Total Revenue (USD Million) (2017-2018)
Table 40. Merck SWOT Analysis
Table 41. Merck Combination Vaccine Product and Services
Table 42. Merck Combination Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Sanofi Pasteur MSD Basic Information, Manufacturing Base and Competitors
Table 44. Sanofi Pasteur MSD Combination Vaccine Major Business
Table 45. Sanofi Pasteur MSD Combination Vaccine Total Revenue (USD Million) (2017-2018)
Table 46. Sanofi Pasteur MSD SWOT Analysis
Table 47. Sanofi Pasteur MSD Combination Vaccine Product and Services
Table 48. Sanofi Pasteur MSD Combination Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. CNBG Basic Information, Manufacturing Base and Competitors
Table 50. CNBG Combination Vaccine Major Business
Table 51. CNBG Combination Vaccine Total Revenue (USD Million) (2017-2018)
Table 52. CNBG SWOT Analysis
Table 53. CNBG Combination Vaccine Product and Services
Table 54. CNBG Combination Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Global Combination Vaccine Sales by Manufacturer (2018-2019) (K Units)
Table 56. Global Combination Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 57. Global Combination Vaccine Sales by Regions (2015-2020) (K Units)
Table 58. Global Combination Vaccine Sales Market Share by Regions (2015-2020)
Table 59. Global Combination Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 60. North America Combination Vaccine Sales by Countries (2015-2020) (K Units)
Table 61. North America Combination Vaccine Sales Market Share by Countries (2015-2020)
Table 62. North America Combination Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 63. North America Combination Vaccine Revenue Market Share by Countries (2015-2020)
Table 64. Europe Combination Vaccine Sales by Countries (2015-2020) (K Units)
Table 65. Europe Combination Vaccine Sales Market Share by Countries (2015-2020)
Table 66. Europe Combination Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 67. Asia-Pacific Combination Vaccine Sales by Regions (2015-2020) (K Units)
Table 68. Asia-Pacific Combination Vaccine Sales Market Share by Regions (2015-2020)
Table 69. Asia-Pacific Combination Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 70. South America Combination Vaccine Sales by Countries (2015-2020) (K Units)
Table 71. South America Combination Vaccine Sales Market Share by Countries (2015-2020)
Table 72. South America Combination Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 73. South America Combination Vaccine Revenue Market Share by Countries (2015-2020)
Table 74. Middle East & Africa Combination Vaccine Sales by Countries (2015-2020) (K Units)
Table 75. Middle East & Africa Combination Vaccine Sales Market Share by Countries (2015-2020)
Table 76. Middle East & Africa Combination Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 77. Middle East & Africa Combination Vaccine Revenue Market Share by Countries (2015-2020)
Table 78. Global Combination Vaccine Sales by Type (2015-2020) (K Units)
Table 79. Global Combination Vaccine Sales Share by Type (2015-2020)
Table 80. Global Combination Vaccine Revenue by Type (2015-2020) (USD Million)
Table 81. Global Combination Vaccine Revenue Share by Type (2015-2020)
Table 82. Global Combination Vaccine Sales by Application (2015-2020) (K Units)
Table 83. Global Combination Vaccine Sales Share by Application (2015-2020)
Table 84. Global Combination Vaccine Sales Forecast by Regions (2021-2025) (K Units)
Table 85. Global Combination Vaccine Market Share Forecast by Regions (2021-2025)
Table 86. Global Combination Vaccine Sales Forecast by Type (2021-2025) (K Units)
Table 87. Global Combination Vaccine Market Share Forecast by Type (2021-2025)
Table 88. Global Combination Vaccine Sales Forecast by Application (2021-2025)
Table 89. Global Combination Vaccine Market Share Forecast by Application (2021-2025)
Table 90. Direct Channel Pros & Cons
Table 91. Indirect Channel Pros & Cons
Table 92. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Combination Vaccine Picture
Figure 2. Global Sales Market Share of Combination Vaccine by Type in 2019
Figure 3. Meningococcal Vaccine Picture
Figure 4. Japanese Encephalitis Vaccine Picture
Figure 5. Yellow Fever Vaccine Picture
Figure 6. Hepatitis Vaccine Picture
Figure 7. Cholera Vaccine Picture
Figure 8. Other Picture
Figure 9. Combination Vaccine Sales Market Share by Application in 2018
Figure 10. Adults Picture
Figure 11. Children Picture
Figure 12. Global Combination Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Combination Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Combination Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Combination Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Combination Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Combination Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Combination Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Combination Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Combination Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Combination Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Combination Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Combination Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Combination Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Combination Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Combination Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Combination Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Combination Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Combination Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Combination Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Combination Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Combination Vaccine Sales Market Share by Manufacturer in 2019
Figure 33. Global Combination Vaccine Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Combination Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Combination Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Combination Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global Combination Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Combination Vaccine Revenue Market Share by Regions (2015-2020)
Figure 40. Global Combination Vaccine Revenue Market Share by Regions in 2018
Figure 41. North America Combination Vaccine Sales and Growth Rate (2015-2020)
Figure 42. Europe Combination Vaccine Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Combination Vaccine Sales and Growth Rate (2015-2020)
Figure 44. South America Combination Vaccine Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Combination Vaccine Sales and Growth Rate (2015-2020)
Figure 46. North America Combination Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Combination Vaccine Sales Market Share by Countries (2015-2020)
Figure 48. North America Combination Vaccine Sales Market Share by Countries in 2018
Figure 49. North America Combination Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Combination Vaccine Revenue Market Share by Countries in 2018
Figure 51. United States Combination Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada Combination Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico Combination Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe Combination Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Combination Vaccine Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Combination Vaccine Revenue Market Share by Countries in 2019
Figure 57. Germany Combination Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK Combination Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France Combination Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia Combination Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy Combination Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific Combination Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Combination Vaccine Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Combination Vaccine Revenue Market Share by Regions 2019
Figure 65. China Combination Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan Combination Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea Combination Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India Combination Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia Combination Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America Combination Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Combination Vaccine Sales Market Share by Countries in 2019
Figure 72. South America Combination Vaccine Revenue Market Share by Countries in 2019
Figure 73. Brazil Combination Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Combination Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa Combination Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Combination Vaccine Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Combination Vaccine Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Combination Vaccine Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Combination Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt Combination Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Combination Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa Combination Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global Combination Vaccine Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global Combination Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Combination Vaccine Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales Combination Vaccine Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales Combination Vaccine Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales Combination Vaccine Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales Combination Vaccine Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
髄膜炎菌グループBワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Meningococcal Group B Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Meningococcal G…- 日本脳炎ウイルスワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Japanese Encephalitis Virus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Japanese …
- モノワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Mono Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Mono Vaccine market report provi…
- 経口コレラワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oral Cholera Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oral Cholera Vaccine mar…
- 全細胞コレラワクチンの世界市場（～2026年） Whole Cell Cholera Vaccine is used to prevent Cholera. The factors that fuel the growth of the global whole cell cholera vaccine (recombinant B-subunit) market are rising incidence of cholera among people in endemic regions along with a lack of sanitation and hygiene in certain countries. Market Ana…